Nymox Pharmaceutical Corp (NYMXF)
0.257
+0.01
(+2.59%)
USD |
OTCM |
May 10, 16:00
Nymox Pharmaceutical Market Cap: 23.97M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 23.97M |
| May 09, 2024 | 23.36M |
| May 08, 2024 | 26.14M |
| May 07, 2024 | 23.36M |
| May 06, 2024 | 23.56M |
| May 03, 2024 | 25.18M |
| May 02, 2024 | 26.11M |
| May 01, 2024 | 30.29M |
| April 30, 2024 | 32.62M |
| April 29, 2024 | 30.31M |
| April 26, 2024 | 27.98M |
| April 25, 2024 | 27.98M |
| April 24, 2024 | 29.84M |
| April 23, 2024 | 27.98M |
| April 22, 2024 | 27.98M |
| April 19, 2024 | 27.07M |
| April 18, 2024 | 27.98M |
| April 17, 2024 | 25.18M |
| April 16, 2024 | 27.98M |
| April 15, 2024 | 33.86M |
| April 12, 2024 | 33.86M |
| April 11, 2024 | 33.86M |
| April 10, 2024 | 36.37M |
| April 09, 2024 | 36.37M |
| April 08, 2024 | 33.58M |
| Date | Value |
|---|---|
| April 05, 2024 | 32.64M |
| April 04, 2024 | 35.44M |
| April 03, 2024 | 35.44M |
| April 02, 2024 | 39.17M |
| April 01, 2024 | 32.64M |
| March 28, 2024 | 37.31M |
| March 27, 2024 | 39.17M |
| March 26, 2024 | 35.31M |
| March 25, 2024 | 29.38M |
| March 22, 2024 | 37.31M |
| March 21, 2024 | 37.31M |
| March 20, 2024 | 33.58M |
| March 19, 2024 | 32.64M |
| March 18, 2024 | 32.27M |
| March 15, 2024 | 38.23M |
| March 14, 2024 | 33.58M |
| March 13, 2024 | 33.58M |
| March 12, 2024 | 33.58M |
| March 11, 2024 | 33.04M |
| March 08, 2024 | 38.94M |
| March 07, 2024 | 37.31M |
| March 06, 2024 | 37.31M |
| March 05, 2024 | 34.51M |
| March 04, 2024 | 41.97M |
| March 01, 2024 | 32.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
17.34M
Minimum
Jun 30 2023
329.91M
Maximum
Jun 15 2020
116.19M
Average
120.07M
Median
Apr 12 2022
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.420M |
| Palatin Technologies Inc | 36.95M |
| iBio Inc | 6.446M |
| Theriva Biologics Inc | 6.289M |
| Oragenics Inc | 8.244M |
Market Cap Related Metrics
| Price | 0.257 |
| Earnings Yield | -19.46% |